Cargando...
Combination immunotherapy using G-CSF and oncolytic virotherapy reduces tumor growth in osteosarcoma
BACKGROUND: Osteosarcoma is the most common malignant solid tumor that affects bones, however, survival rates of patients with relapsed osteosarcoma have not improved in the last 30 years. Oncolytic virotherapy, which uses viruses designed to selectively replicate in cancer cells, has emerged as a p...
Guardado en:
| Publicado en: | J Immunother Cancer |
|---|---|
| Autores principales: | , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
BMJ Publishing Group
2021
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7978281/ https://ncbi.nlm.nih.gov/pubmed/33737338 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2020-001703 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|